Tyra Biosciences stock soars more than 60% on public debut
Shares of oncology biotech company Tyra Biosciences (TYRA) jumped more than 60% on their first day of trading Wednesday. Tyra raised $173 million by offering 10.8 million shares at $16, at the high end of expectations between $14 and $16 and an upsized deal. Tyra is one of several newly minted companies trading on Wednesday above their IPO range and a busy week for initial public offerings, with 2021 shaping up the biggest year ever for IPO proceeds
(END) Dow Jones Newswires
September 15, 2021 10:41 ET (14:41 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.